Workflow
Surmodics(SRDX)
icon
Search documents
Surmodics(SRDX) - 2022 Q4 - Earnings Call Presentation
2022-11-13 01:44
1 | --- | --- | --- | |----------------------------------------------------------------------|-------|-------| | | | | | | | | | Gary Maharaj President and CEO | | | | Tim Arens Senior Vice President of Finance, IT and CFO November 2022 | | | © 2022 Surmodics, Inc. CONFIDENTIAL All rights reserved. 2 Safe Harbor Some of the statements made during this presentation may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not ...
Surmodics(SRDX) - 2022 Q3 - Earnings Call Transcript
2022-07-27 19:36
Surmodics, Inc. (NASDAQ:SRDX) Q3 2022 Earnings Conference Call July 27, 2022 8:30 AM ET Company Participants Gary Maharaj - President and Chief Executive Officer Tim Arens - Senior Vice President of Finance and Information Technology and Chief Financial Officer Conference Call Participants Brooks O’Neil - Lake Street Capital Markets Jim Sidoti - Sidoti & Company Mike Matson - Needham & Company Operator Good day, and welcome to the Surmodics’ Third Quarter Fiscal 2022 Earnings Conference Call. Today's confe ...
Surmodics(SRDX) - 2022 Q3 - Quarterly Report
2022-07-27 18:09
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 0-23837 Surmodics, Inc. (Exact name of registrant as specified in its charter) Indicate by check mark whether the registrant is a large accelerated filer, an acceler ...
Surmodics(SRDX) - 2022 Q1 - Earnings Call Presentation
2022-05-03 07:36
1 | --- | --- | --- | |---------------------------------------------------------|-------|-------| | | | | | | | | | Gary Maharaj President and CEO | | | | Tim Arens | | | | Senior Vice President of Finance, IT and CFO April 2022 | | | © 2022 Surmodics, Inc. CONFIDENTIAL All rights reserved. 2 Safe Harbor Some of the statements made during this presentation may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historic ...
Surmodics(SRDX) - 2022 Q2 - Earnings Call Transcript
2022-04-27 19:42
Surmodics, Inc. (NASDAQ:SRDX) Q2 2022 Earnings Conference Call April 27, 2022 8:30 AM ET Company Participants Tim Arens - SVP, Finance & CFO Gary Maharaj - President & CEO Conference Call Participants David Saxon - Needham Brooks O'Neil - Lake Street Capital Markets Jim Sidoti - Sidoti & Company Mike Petusky - Barrington Research Operator Good day, and welcome to the Surmodics Second Quarter Fiscal 2022 Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference ...
Surmodics(SRDX) - 2022 Q2 - Quarterly Report
2022-04-27 18:35
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 0-23837 Surmodics, Inc. (Exact name of registrant as specified in its charter) MINNESOTA 41-1356149 9924 West 74th Street, Eden Prairie, Minnesota 55344 (Address of ...
Surmodics(SRDX) - 2022 Q1 - Quarterly Report
2022-02-04 02:17
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 0-23837 Surmodics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Id ...
Surmodics(SRDX) - 2022 Q1 - Earnings Call Transcript
2022-02-03 17:57
Surmodics, Inc. (NASDAQ:SRDX) Q1 2022 Earnings Conference Call February 3, 2022 8:30 AM ET Company Participants Tim Arens - SVP, Finance & CFO Gary Maharaj - President & CEO Conference Call Participants Brooks O’Neil - Lake Street Capital Markets David Saxon - Needham and Company Mike Petusky - Barrington Research Jim Sidoti - Sidoti & Company Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help ...
Surmodics (SRDX) Investor Presentation - Slideshow
2022-01-21 19:55
1 | --- | --- | |-----------------------------------------------------------|-------| | | | | | | | Gary Maharaj President and CEO | | | Tim Arens | | | Senior Vice President of Finance, IT and CFO January 2022 | | © 2022 Surmodics, Inc. CONFIDENTIAL All rights reserved. 2 Safe Harbor Some of the statements made during this presentation may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not historical or current facts, ...
Surmodics(SRDX) - 2021 Q4 - Annual Report
2021-11-24 16:36
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number 0-23837 Surmodics, Inc. (Exact name of Registrant as specified in its Charter) (State or other jurisdiction of incorpo ...